Eric I. Richman
2020 - Gain Therapeutics
In 2020, Eric I. Richman earned a total compensation of $277.1K as Chief Executive Officer at Gain Therapeutics.
Compensation breakdown
| Bonus | $30,000 |
|---|---|
| Non-Equity Incentive Plan | $37,500 |
| Option Awards | $63,843 |
| Salary | $131,250 |
| Other | $14,540 |
| Total | $277,133 |
Richman received $131.3K in salary, accounting for 47% of the total pay in 2020.
Richman also received $30K in bonus, $37.5K in non-equity incentive plan, $63.8K in option awards and $14.5K in other compensation.
Rankings
In 2020, Eric I. Richman's compensation ranked 12,229th out of 13,090 executives tracked by ExecPay. In other words, Richman earned more than 6.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,229 out of 13,090 | 7th |
Division Manufacturing | 5,240 out of 5,624 | 7th |
Major group Chemicals And Allied Products | 2,128 out of 2,257 | 6th |
Industry group Drugs | 1,850 out of 1,957 | 6th |
Industry Pharmaceutical Preparations | 1,373 out of 1,462 | 6th |
Source: SEC filing on May 13, 2022.
Richman's colleagues
We found one more compensation record of an executive who worked with Eric I. Richman at Gain Therapeutics in 2020.
2020
Salvatore Calabrese
Gain Therapeutics